Endovascular Today4d
CVRx Barostim Procedure Assigned CMS New Technology Outpatient Payment
CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...
Endovascular Today2d
Akura Receives IDE Approval for QUADRA-PE Pivotal Trial of Katana System
Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...
Endovascular Today10d
CMS Grants TPT Payment for Medtronic’s Symplicity Spyral RDN and Recor’s Paradise uRDN Systems
Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...
Endovascular Today7d
Resource Utilization and Outcomes With Penumbra’s CAVT in Intermediate-Risk PE Patients Compared to Other Treatment Modalities
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with intermediate-risk ...
Endovascular Today6d
PROMISE II Trial Evaluates TADV With Inari’s LimFlow System
Two-year outcomes from the PROMISE II trial assessed transcatheter arterialization of the deep veins (TADV) using the LimFlow S ...
Endovascular Today8d
Study Assesses Effects of Intravascular Volume Expansion on Deep Pelvic Vein Size
A study assessed the effects of intravascular volume expansion on deep pelvic vein size using the 200-150-125 rule for the ...
Endovascular Today7d
CLOUT Registry’s 2-Year Outcomes Reported for Inari’s ClotTriever to Treat DVT
Two-year outcomes were reported from the CLOUT registry, which is a prospective, multicenter study evaluating patient outcomes ...
Endovascular Today8d
Medtronic’s VenaSeal Closure Compared to Surgical Stripping in 6-Month Data
Secondary outcomes through 6 months were reported from the VenaSeal Spectrum Surgical Stripping study, a randomized ...
Endovascular Today6d
DEEPER OUS 2-Year Data Assess Reflow’s Spur Retrievable Spur System Combined With Paclitaxel DCB
DEEPER OUS is a prospective, nonrandomized, multicenter, single-arm trial taking place in New Zealand, Germany, and Switzerland ...
Endovascular Today6d
Philips Begins Pivotal THOR Trial of Combined Device to Treat PAD
Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...
Endovascular Today4d
LIFE-BTK Trial Implemented Several Enrollment Initiatives to Facilitate Inclusion of Diverse Populations
In the LIFE-BTK trial, several initiatives were implemented to facilitate enrollment of diverse populations, ensuring that pati ...
Endovascular Today7d
ROADSTER 3 Data Reported for Boston Scientific’s Enroute TCAR Devices
The prospective, multicenter ROADSTER 3 postapproval trial is evaluating the safety and effectiveness of transcarotid artery re ...